InstitutionClaim Cited
After an infected traveler reached Lagos in July 2014, Nigeria joined federal and state authority, polio-program staff, field epidemiologists, laboratories, clinicians, contact tracers, and international partners in one incident-management system. The system shortened coordination and feedback paths, but it operated only because clinicians acted before it existed, workers accepted grave risk, contacts submitted to intrusive monitoring, and communities negotiated fear, stigma, privacy, and quarantine.
How can an emergency organization turn incomplete reports into coordinated action quickly enough to interrupt transmission without losing trust, worker safety, privacy, or correction?
InstitutionClaim Cited
In 2003, political and religious leaders in several northern Nigerian states halted oral polio vaccination after alleging that the vaccine was contaminated. Federal, state, and international testing processes concluded that the vaccine was safe, but research with northern Nigerian residents and documentary scholarship locate refusal in a wider legitimacy problem: political distrust, a disputed earlier drug trial, and repeated polio campaigns amid weak access to basic care. Negotiated testing, trusted local authorities, women mobilizers, integrated services, surveillance, and sustained operations accompanied the 2004 resumption and Nigeria's eventual interruption of wild poliovirus. Wild poliovirus was last detected in 2016 and the African Region was certified free of it in 2020, while circulating vaccine-derived poliovirus type 2 remained active in Nigeria through 2026.
How did a technically safe vaccine lose legitimacy in northern Nigeria, and what organizational changes made trust possible again?